Tretinoin Microsponge Gel data

APOS presented preliminary results of its two pivotal efficacy studies in 360 patients with both inflammatory lesions (pimples) and non-inflammatory lesions (whiteheads and blackheads). Sergio Nacht, senior vice president of R&D, said there was a statistically significant improvement in inflammatory lesions in the 180-patient treatment group compared to vehicle (p=0.008) and in non-inflammatory lesions versus vehicle (p=0.001). The global evaluation of both types of lesions was also statistically significant for treatment versus placebo (p=0.001). ...